BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 7, 2009
View Archived Issues
Activity seen with eniluracil and 5-fluorouracil in hepatocellular carcinoma
Read More
Ferric carboxymaltose improves restless legs syndrome in double-blind study
Read More
Fate Therapeutics acquires intellectual property rights to osteogenic agents from UC
Read More
Morphotek and Synageva sign research collaboration for therapeutic monoclonal antibodies
Read More
Clopidogrel with aspirin reduces vascular event risk in atrial fibrillation patients
Read More
Study tests carotid plaque inflammation biomarker, atorvastatin effects
Read More
High response rates to RFB4(dsFv)-PE38 treatment in hairy cell leukemia
Read More
Actelion receives E.U. approval for pediatric dispersible formulation of Tracleer for PAH
Read More
Alcon initiates treatment in phase II trial of NovaBay's NVC-422 for viral conjunctivitis
Read More
Salvat launches antibiotic Cetraxal for otitis externa in the U.S.
Read More
Genentech reports results from phase III BRAVO study of Lucentis in branch RVO
Read More
GSK discontinues development of Kissei's SGLT2 inhibitor remogliflozin for diabetes
Read More
Sigma-Tau submits MAA to EMEA for antimalarial Eurartesim
Read More
Novartis enrolls first patient in phase III study of Sosei's NVA-237 for COPD
Read More
FDA approves Lilly's Alimta as maintenance therapy for NSCLC
Read More
Eisai to initiate U.S. clinical trial of Dacogen in pediatric AML
Read More
Initial tender offer for Cougar Biotechnology completed by Johnson & Johnson
Read More
Oxigene to acquire Symphony Vida and rights to OXi-4503 and Zybrestat for ophthalmology
Read More
BioCis Pharma reports results from phase IIa clinical trial of ProtoCure in dermatitis
Read More
Action Pharma discovers and patents novel melanocortin receptor ligands
Read More
Cellzome presents PI3Kgamma inhibitors for the treatment of immunological disorders
Read More
Polyamine analogues active against Enterocytozoon bieneusi in mouse model
Read More
Bar-Ilan University patent describes novel P2Y1 receptor agonists
Read More
Cubist initiates dosing in CONSERV-2 clinical trial of ecallantide for blood loss in surgery
Read More
CBP-501 initiates phase II clinical studies for non-small cell lung cancer
Read More